YourWay Cannabis Brands Inc.

CNSX:YOUR Stock Report

Market Cap: CA$23.2m

YourWay Cannabis Brands Past Earnings Performance

Past criteria checks 3/6

YourWay Cannabis Brands has been growing earnings at an average annual rate of 21.1%, while the Pharmaceuticals industry saw earnings growing at 27.3% annually. Revenues have been growing at an average rate of 104.2% per year. YourWay Cannabis Brands's return on equity is 18.4%, and it has net margins of 4.5%.

Key information

21.1%

Earnings growth rate

77.9%

EPS growth rate

Pharmaceuticals Industry Growth23.1%
Revenue growth rate104.2%
Return on equity18.4%
Net Margin4.5%
Last Earnings Update30 Sep 2021

Recent past performance updates

Robust Earnings May Not Tell The Whole Story For Hollister Biosciences (CSE:HOLL)

Sep 01
Robust Earnings May Not Tell The Whole Story For Hollister Biosciences (CSE:HOLL)

Recent updates

Robust Earnings May Not Tell The Whole Story For Hollister Biosciences (CSE:HOLL)

Sep 01
Robust Earnings May Not Tell The Whole Story For Hollister Biosciences (CSE:HOLL)

Hollister Biosciences (CSE:HOLL) Shareholders Have Enjoyed An Impressive 115% Share Price Gain

Dec 28
Hollister Biosciences (CSE:HOLL) Shareholders Have Enjoyed An Impressive 115% Share Price Gain

Revenue & Expenses Breakdown
Beta

How YourWay Cannabis Brands makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CNSX:YOUR Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2167340
30 Jun 2162240
31 Mar 2153040
31 Dec 2031-440
30 Sep 2019-440
30 Jun 2010-330
31 Mar 202-420
31 Dec 191-210
31 Dec 180-100

Quality Earnings: YOUR has high quality earnings.

Growing Profit Margin: YOUR became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: YOUR has become profitable over the past 5 years, growing earnings by 21.1% per year.

Accelerating Growth: YOUR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: YOUR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (109.7%).


Return on Equity

High ROE: YOUR's Return on Equity (18.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.